Skip to main content

Flora Growth Strengthens Board With New Independent Director

Tipranks - Wed Jan 7, 3:44PM CST

Claim 70% Off TipRanks Premium

Flora Growth ( (FLGC) ) just unveiled an update.

On January 6, 2026, Flora Growth Corp.’s board appointed Larry Zeifman as a director and chair of the audit committee, as well as a member of the audit, compensation, and nominating and corporate governance committees, while naming Manfred Leventhal as chair of the nominating committee. Zeifman, deemed an independent director under Nasdaq and SEC standards and free of related-party or compensatory arrangements tied to his appointment, fills the board and committee vacancies created by the death of director Harold Wolkin on August 25, 2025, reinforcing Flora Growth’s governance structure and regulatory compliance credentials for investors and other stakeholders.

The most recent analyst rating on (FLGC) stock is a Hold with a $6.50 price target. To see the full list of analyst forecasts on Flora Growth stock, see the FLGC Stock Forecast page.

Spark’s Take on FLGC Stock

According to Spark, TipRanks’ AI Analyst, FLGC is a Neutral.

The score is held down primarily by weak financial performance (declining revenue, persistent losses, and ongoing cash burn) and bearish technicals (price below key moving averages with negative MACD). Corporate events provide a moderate offset via financing flexibility, but valuation is constrained by negative earnings and no dividend support.

To see Spark’s full report on FLGC stock, click here.

More about Flora Growth

Flora Growth Corp. operates in the cannabis and wellness sector, focusing on cultivating and supplying cannabis-derived products and related consumer goods for domestic and international markets.

Average Trading Volume: 36,824

Technical Sentiment Signal: Sell

Current Market Cap: $5.53M

See more data about FLGC stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.